Correction: MiR-451 as a new tumor marker for gastric cancer

Yong Shen; Jiao-Mei Gong; Li-Li Zhou; Jia-He Sheng

doi:10.18632/oncotarget.27291

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: MiR-451 as a new tumor marker for gastric cancer

PDF | How to cite

Oncotarget. 2019; 10:6396-6396. https://doi.org/10.18632/oncotarget.27291

Metrics: PDF 1169 views | ?

Yong Shen^1,2, Jiao-Mei Gong³, Li-Li Zhou⁴ and Jia-He Sheng²

¹ Department of Pathology and Pathophysiology, Medical School of Southeast University, Nanjing, Jiangsu, China
² Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China
³ Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
⁴ Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China

Published: October 29, 2019

This article has been corrected: The authors' affiliation information was listed incorrectly. The proper affiliations are as follows:

Original article: Oncotarget. 2017; 8:56542–56545. DOI: https://doi.org/10.18632/oncotarget.17239.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27291

Publication Alerts

Corrections:

Correction: MiR-451 as a new tumor marker for gastric cancer